Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol by Redman, Mary W, Prof, Papadimitrakopoulou, Vassiliki A, Prof, Minichiello, Katherine, MS, Hirsch, Fred R, Prof, Mack, Philip C, PhD, Schwartz, Lawrence H, Prof, Vokes, Everett, Prof, Ramalingam, Suresh, Prof, Leighl, Natasha, MD, Bradley, Jeff, Prof, Miao, Jieling, MS, Moon, James, MS, Highleyman, Louise, BS, Miwa, Crystal, BS, LeBlanc, Michael L, Prof, Malik, Shakun, MD, Miller, Vincent A, MD, Sigal, Ellen V, PhD, Adam, Stacey, PhD, Wholley, David, MS, Sigman, Caroline, PhD, Smolich, Beverly, PhD, Blanke, Charles D, Prof, Kelly, Karen, Prof, Gandara, David R, Prof, Herbst, Roy S, Prof

Get full text

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study by Cohen, Ezra EW, Dr, Davis, Darren W, PhD, Karrison, Theodore G, PhD, Seiwert, Tanguy Y, MD, Wong, Stuart J, MD, Nattam, Sreenivasa, MD, Kozloff, Mark F, MD, Clark, Joseph I, MD, Yan, Duen-Hwa, PhD, Liu, Wen, MD, Pierce, Carolyn, BA, Dancey, Janet E, MD, Stenson, Kerstin, MD, Blair, Elizabeth, MD, Dekker, Allison, BSN, Vokes, Everett E, Prof

Get full text